Easy does it! New EZH2 inhibitor SHR2554 is safe and active in relapsed or refractory lymphoma
Year: 2022
Type: article
Source: The Lancet Haematology
Authors: Yun Kyoung Ryu, Jennifer E Amengual
Institution: Columbia University Irving Medical Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W4283658561